Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Study Overview
=================
Brief Summary
-----------------
Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?

Detailed Description
-----------------
To evaluate if a monthly adherence monitoring and education service impacts the percent of patients adherent to oral diabetes and renin-angiotensin system antagonists (RASA) medications based on star ratings. It will also evaluate patient satisfaction of the adherence monitoring and education service, using a standard questionnaire.

Official Title
-----------------
Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Conditions
-----------------
Adherence, Patient

Intervention / Treatment
-----------------
* Behavioral: Adherence monitoring and education


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 18 years or older Patients pre-identified by Kroger analytics in ClinicalQ - Patients with PDC < 80% Patient taking oral diabetes medications and/or RASA medications (ACE-I, ARB, direct renin inhibitor) Exclusion Criteria: Patients who are enrolled in MedSync or Autorefill program Patients who are lost to follow-up Incomplete/missing documentation of an encounter Prisoners, children

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Adherence monitoring and education<br> | Behavioral: Adherence monitoring and education<br>* Standardized medication counseling and education combined with individual patient customized guidance and counseling - administered monthly.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Adherence in oral diabetes medications determined by star ratings | Determine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference. | Baseline to 6 months | 
| Adherence in renin-angiotensin system antagonists (RASA) medications determined by star ratings | Determine change in patients who are adherent to RASA medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference. | Baseline to 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in proportion of days covered (PDC) | Determine change in PDC after monthly follow-up on medication adherence and education; pharmacy analytics determines patient PDC in normal practice. The mean PDC for each patient at the end of the six-month study period will be compared to the baseline using a student t-test. | Baseline to 6 months |